Faron Pharmaceuticals Oy (DI) (FARN) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Jul 2021 07:00 AM
RNS
Faron to Host KOL Webinar on Clever-1 Receptor
22 Jun 2021 07:00 AM
RNS
Updated corporate presentation
14 Jun 2021 11:05 AM
RNS
Second Price Monitoring Extn
14 Jun 2021 11:00 AM
RNS
Price Monitoring Extension
14 Jun 2021 07:00 AM
RNS
Bexmarilimab granted key US patent
03 Jun 2021 07:00 AM
RNS
Bexmarilimab results published in CCR
17 May 2021 07:00 AM
RNS
Bexmarilimab shows promising anti-tumour activity
14 May 2021 07:00 AM
RNS
US rights to patent related to Traumakine
10 May 2021 02:30 PM
RNS
Holding(s) in Company
29 Apr 2021 12:45 PM
RNS
Grant of options
23 Apr 2021 01:45 PM
RNS
Result of AGM
23 Apr 2021 01:45 PM
RNS
Board Change
29 Mar 2021 07:00 AM
RNS
Appointment of a Broker
25 Mar 2021 07:45 AM
RNS
Exercise of Options
25 Mar 2021 07:30 AM
RNS
Notice of Faron Pharmaceuticals Ltd's AGM
25 Mar 2021 07:15 AM
RNS
Faron´s Annual Report 2020 published
25 Mar 2021 07:00 AM
RNS
Financial statement January 1 to December 31 2020
22 Mar 2021 07:00 AM
RNS
Bexmarilimab (Clevegen) development update
11 Mar 2021 07:00 AM
RNS
Faron to Present at Oppenheimer Conference
02 Mar 2021 07:00 AM
RNS
Faron to Present at H.C. Wainwright Conference
25 Feb 2021 07:00 AM
RNS
Notice of Full-Year Results and Annual Report
17 Feb 2021 04:30 PM
RNS
Holding(s) in Company
12 Feb 2021 03:00 PM
RNS
Registration of Placing Shares
12 Feb 2021 07:00 AM
RNS
Results of Placing and Issue Price
11 Feb 2021 04:30 PM
RNS
Proposed Issue and Placing of Shares
26 Jan 2021 07:00 AM
RNS
Update on TRAUMAKINE development
20 Jan 2021 02:06 PM
RNS
Second Price Monitoring Extn
20 Jan 2021 02:01 PM
RNS
Price Monitoring Extension
20 Jan 2021 07:00 AM
RNS
Bexmarilimab (Clevegen) development update
18 Jan 2021 02:05 PM
RNS
Second Price Monitoring Extn
18 Jan 2021 02:00 PM
RNS
Price Monitoring Extension
18 Jan 2021 11:06 AM
RNS
Second Price Monitoring Extn
18 Jan 2021 11:01 AM
RNS
Price Monitoring Extension
18 Jan 2021 07:00 AM
RNS
US Department of Defense to support TRAUMAKINE
04 Jan 2021 07:00 AM
RNS
Faron to Present at H.C. Wainwright
21 Dec 2020 07:00 AM
RNS
Faron's financial calendar for 2021
10 Dec 2020 07:00 AM
RNS
Presents at ESMO Immuno-Oncology Virtual Congress
23 Nov 2020 07:30 AM
RNS
To Participate in Upcoming Investor Conferences
23 Nov 2020 07:00 AM
RNS
Bexmarilimab (Clevegen) development update
20 Nov 2020 07:00 AM
RNS
Issue of Equity
16 Oct 2020 11:35 AM
RNS
First Results from WHO Solidarity Trial
14 Oct 2020 02:15 PM
RNS
Grant of options
30 Sep 2020 09:45 AM
RNS
Holding(s) in Company
24 Sep 2020 07:15 AM
RNS
Exercise of options
24 Sep 2020 07:00 AM
RNS
Half-year Report
18 Sep 2020 07:00 AM
RNS
MATINS trial data presented at ESMO
09 Sep 2020 12:00 PM
RNS
Faron to Present at H.C. Wainwright Conference
27 Aug 2020 07:00 AM
RNS
Notice of Half-Year Report
18 Aug 2020 07:00 AM
RNS
Traumakine Update
17 Aug 2020 04:41 PM
RNS
Second Price Monitoring Extn
UK 100

Latest directors dealings